175
Views
1
CrossRef citations to date
0
Altmetric
Commentary

Chemo-immunotherapy: a new option for non-small cell lung cancer

Pages 503-504 | Published online: 15 Mar 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Cirino Botta, Vito Barbieri, Domenico Ciliberto, Antonio Rossi, Danilo Rocco, Raffaele Addeo, Nicoletta Staropoli, Pierpaolo Pastina, Giulia Marvaso, Ignazio Martellucci, Annamaria Guglielmo, Luigi Pirtoli, Pasquale Sperlongano, Cesare Gridelli, Michele Caraglia, Pierfrancesco Tassone, Pierosandro Tagliaferri & Pierpaolo Correale. (2013) Systemic inflammatory status at baseline predicts bevacizumab benefit in advanced non-small cell lung cancer patients. Cancer Biology & Therapy 14:6, pages 469-475.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.